{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:45:16Z","timestamp":1778910316996,"version":"3.51.4"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.601555","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T06:26:58Z","timestamp":1605594418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and Replication"],"prefix":"10.3389","volume":"11","author":[{"given":"Zsolt","family":"Ruzsics","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalbert","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Widera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Sertznig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Kapper-Falcone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Debreczeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reingard","family":"Grabherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Harant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J. Virol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1128\/AAC.01424-07","article-title":"Inhibition of herpes simplex virus type 1 infection by cationic-peptides","volume":"52","author":"Akkarawongsa","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1128\/AAC.46.8.2381-2386.2002","article-title":"Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro","volume":"46","author":"Beadle","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e40585","DOI":"10.1371\/journal.pone.0040585","article-title":"A beta-herpesvirus with fluorescent capsids to study transport in living cells","volume":"7","author":"Bosse","year":"2012","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"36018","DOI":"10.1074\/jbc.M204849200","article-title":"Peptides containing membrane-transiting motifs inhibit virus entry","volume":"277","author":"Bultmann","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1128\/AAC.01009-06","article-title":"Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain","volume":"51","author":"Bultmann","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.antiviral.2012.12.006","article-title":"Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus","volume":"97","author":"Chono","year":"2013","journal-title":"Antivir. Res."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.matbio.2013.10.004","article-title":"Heparan sulfate proteoglycan as a cell-surface endocytosis receptor","volume":"35","author":"Christianson","year":"2014","journal-title":"Matrix Biol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nm0402-386","article-title":"Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease","volume":"8","author":"Crute","year":"2002","journal-title":"Nat. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bjp.0706446","article-title":"Antiviral prodrugs \u2013 the development of successful prodrug strategies for antiviral chemotherapy","volume":"147","author":"De Clercq","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1006\/viro.1999.0171","article-title":"Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions","volume":"268","author":"Dechecchi","year":"2000","journal-title":"Virology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1128\/JVI.78.5.2637-2641.2003","article-title":"Identification of peptides that inhibit the dna binding, trans-activator, and DNA replication functions of the human papillomavirus type 11 E2 protein","volume":"78","author":"Deng","year":"2004","journal-title":"J. Virol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/clpt.2010.178","article-title":"Update on new antivirals under development for the treatment of double-stranded dna virus infections","volume":"88","author":"Dropulic","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/(SICI)1521-2254(199903\/04)1:2<93::AID-JGM19>3.0.CO;2-1","article-title":"Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells","volume":"1","author":"Duisit","year":"1999","journal-title":"J. Gene Med."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1099\/0022-1317-2-3-357","article-title":"Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells","volume":"2","author":"Ejercito","year":"1968","journal-title":"J. Gen. Virol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1073\/pnas.74.12.5716","article-title":"Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine","volume":"74","author":"Elion","year":"1977","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell"},{"key":"ref21","author":"Harant","year":"2017"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"26954","DOI":"10.1074\/jbc.271.43.26954","article-title":"Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor-\u03b1 involves the transcription factor NF-\u03baB","volume":"271","author":"Harant","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1126\/science.287.5453.646","article-title":"Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells","volume":"287","author":"Hazuda","year":"2000","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.210500","article-title":"Trisodium phosphonoformate, a new antiviral compound","volume":"201","author":"Helgstrand","year":"1978","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"42625","DOI":"10.1074\/jbc.M301431200","article-title":"Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 tat protein are transferred to mammalian cells by endocytosis-mediated pathways","volume":"278","author":"Ignatovich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1167\/iovs.12-10250","article-title":"A cationic peptide, TAT-Cd 0, inhibits herpes simplex virus type 1 ocular infection in vivo","volume":"54","author":"Jose","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0092-8674(84)90457-4","article-title":"A short amino acid sequence able to specify nuclear location","volume":"39","author":"Kalderon","year":"1984","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1128\/JCM.38.7.2638-2642.2000","article-title":"Detection of herpes simplex virus DNA by real-time PCR","volume":"38","author":"Kessler","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm0402-392","article-title":"New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease","volume":"8","author":"Kleymann","year":"2002","journal-title":"Nat. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1128\/JVI.02409-07","article-title":"Selective ablation of virion host shutoff protein RNase activity attenuates herpes simplex virus 2 in mice","volume":"82","author":"Korom","year":"2008","journal-title":"J. Virol."},{"key":"ref32","author":"Koszinowski","year":"2016"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1073\/pnas.1220019110","article-title":"Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody","volume":"110","author":"Krawczyk","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1128\/jvi.01924-10","article-title":"Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus","volume":"85","author":"Krawczyk","year":"2010","journal-title":"J. Virol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.vaccine.2014.02.011","article-title":"Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine","volume":"32","author":"Lackner","year":"2014","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/095632020501600302","article-title":"Achievements and challenges in antiviral drug discovery","volume":"16","author":"Littler","year":"2005","journal-title":"Antivir. Chem. Chemother."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plasmid.2018.05.002","article-title":"Baculovirus for gene delivery to mammalian cells: Past, present and future","volume":"98","author":"Mansouri","year":"2018","journal-title":"Plasmid"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd1331","article-title":"Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes","volume":"3","author":"Matthews","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1073\/pnas.82.20.7096","article-title":"3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virus in vitro","volume":"82","author":"Mitsuya","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.virol.2008.10.016","article-title":"Insights into adenovirus host cell interactions from structural studies","volume":"384","author":"Nemerow","year":"2009","journal-title":"Virology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(12)61853-4","article-title":"Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study","volume":"381","author":"Raffi","year":"2013","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"15300","DOI":"10.1074\/jbc.M401604200","article-title":"Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors","volume":"280","author":"Richard","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.drudis.2014.09.017","article-title":"Therapeutic applications of the cell-penetrating HIV-1 Tat peptide","volume":"20","author":"Rizzuti","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.2183354","article-title":"Rational design of peptide-based HIV proteinase inhibitors","volume":"248","author":"Roberts","year":"1990","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1021\/jm0600139","article-title":"Novel HIV-1 integrase inhibitors derived from quinolone antibiotics","volume":"49","author":"Sato","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/272583a0","article-title":"9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group","volume":"272","author":"Schaeffer","year":"1978","journal-title":"Nature"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1021\/bc9600630","article-title":"In vitro gene delivery by degraded polyamidoamine dendrimers","volume":"7","author":"Tang","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e1002069","DOI":"10.1371\/journal.ppat.1002069","article-title":"Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-\u03b3-stimulated cells","volume":"7","author":"Trilling","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12977-014-0072-1","article-title":"A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction","volume":"11","author":"Widera","year":"","journal-title":"Retrovirology"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-6405-11-1","article-title":"The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity","volume":"11","author":"Widera","year":"","journal-title":"AIDS Res. Ther."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1073\/pnas.96.1.91","article-title":"Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus","volume":"96","author":"Zanta","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus receptors","volume":"79","author":"Zhang","year":"2005","journal-title":"J. Virol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.celrep.2017.05.008","article-title":"An engineered virus library as a resource for the spectrum-wide exploration of virus and vector diversity","volume":"19","author":"Zhang","year":"2017","journal-title":"Cell Rep."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3967\/0895-3988.2011.01.011","article-title":"How does cellular heparan sulfate function in viral pathogenicity?","volume":"24","author":"Zhu","year":"2011","journal-title":"Biomed. Environ. Sci."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3389\/fmicb.2015.00517","article-title":"Broad-spectrum antiviral agents","volume":"6","author":"Zhu","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0006-3495(04)74101-6","article-title":"Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters","volume":"86","author":"Ziegler","year":"2004","journal-title":"Biophys. J."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.1021\/bi700416h","article-title":"High affinity of the cell-penetrating peptide HIV-1 Tat-PTD for DNA","volume":"46","author":"Ziegler","year":"2007","journal-title":"Biochemistry"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.antiviral.2017.11.012","article-title":"A new promising candidate to overcome drug resistant herpes simplex virus infections","volume":"149","author":"Zinser","year":"2018","journal-title":"Antivir. Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2020.601555\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T06:27:10Z","timestamp":1605594430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2020.601555\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":61,"alternative-id":["10.3389\/fmicb.2020.601555"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.601555","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"article-number":"601555"}}